$CTSH

Cognizant (NASDAQ: CTSH) director now holds 21,794 deferred units

Cognizant (CTSH) director Stephen J. Rohleder acquired 225.3652 deferred and restricted stock units, bringing his total to 21,794.4158 units. These units are linked to Class A Common Stock and are fully vested, with settlement deferred under the company's guidelines. The units were acquired through dividend equivalent rights on previously outstanding units at $0.00 per unit.

Original reporting
Published Aug 27, 2026, 8:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 4:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CTSH
Neutral
high confidence
Mentioned
$CTSH
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CTSHNeutralLow
01

Why it matters

The grant is non‑material and unlikely to affect short‑term price action, but it confirms ongoing director compensation practices.

02

Market read

A routine insider award with no immediate market impact; primarily of interest to compliance and governance watchers.

03

What to watch

The units vest fully and are deferred until a change‑in‑control event, which could become relevant in a merger scenario.

Relevance 4/10Novelty 4/10Timing: post‑award filing on Aug 25 2026

Background

Cognizant disclosed a routine director compensation award via an SEC Form 4 filing.

Company-level read

Ticker impact

$CTSHNeutralHigh confidence
Context

Director Stephen J. Rohleder was awarded 113.4588 Deferred Stock Units and 111.9064 Restricted Stock Units on Aug 25 2026, increasing his total deferred unit balance to 21,794.4158 units.

Expected impact

Minimal impact; no immediate buying pressure expected.

Evidence & confidence

Form 4 filing discloses a small, zero‑price grant to a non‑employee director; such insider awards are routine and not material to valuation.

Market effects

None; the filing is company‑specific and does not affect the broader IT services sector.

None; limited to Cognizant investors.

Low; no cross‑border implications.

Counterpoint

If the director’s compensation structure signals confidence in future performance, some investors might view the grant as a subtle bullish cue.

Key entities

  • Cognizant Technology Solutions Corp.

    US‑listed IT services firm (NASDAQ: CTSH).

  • Stephen J. Rohleder

    Non‑employee director of Cognizant receiving the award.

Related articles

$CTSHMedAI 8/10

Cognizant's AI Gamble: What Nearshore Must Learn

Cognizant reported Q2 2026 revenue growth of 4.5%, down from Q2 2025, but beat peers and met guidance. Bookings fell 6% YoY. The company raised full-year EPS guidance to $5.70-$5.82, and its stock surged 41.81% in a month. Cognizant cited AI-led demand and partnerships with Google Cloud and Anthropic.

$CTSHMed

Anthropic Is Only Part of the Story. Cognizant Has a Much Bigger AI Plan.

Cognizant (CTSH) trades at a discount versus its historical valuation, with forward GAAP P/E of 8.31x and P/S of 0.97x. In Q2, it reported EPS $1.37 vs $1.38 expected, 4.5% revenue growth, and $459M free cash flow. Management guided Q3 growth 3.8%-5.3% YoY and FY EPS to $5.76 midpoint. Guggenheim cut its price target to $65 but kept a Buy; analysts’ mean target is $60.12.

$CTSHMedAI 8/10

Cognizant Technology Solutions Corporation Q2 2026 Earnings Call Summary

Cognizant Technology Solutions reported 4.1% year-over-year constant-currency revenue growth in Q2 2026, driven by North America and 12% growth in financial services. The company revised full-year revenue guidance to 4% to 5.5% growth and kept adjusted operating margin at 16% to 16.2%. It cited an $81M one-time India benefit, Project LEAP costs, and interest expense after a $1B Astreya-related draw.

$CTSHMed

Cognizant Earnings: Financial Services and North America Drive Resilient Performance

Morningstar’s stock note says Cognizant (CTSH) reported 4% Q2 constant-currency revenue growth, with operating margin steady at 16% and trailing 12-month bookings up 5%. It attributes results to North America and financial services, where growth was 12%. Morningstar keeps a $84 fair value estimate and 16.0%-16.2% operating margin guidance, while trimming full-year revenue growth outlook to 4.0%-5.5%.